ARDAN PHARMA A novel way to modulate inflammation Cancer treatment Opportunity 30% of cancer patients undergoing checkpoint immunotherapies are refractory or develop resistance to the treatment, representing a key unmet medical need. These breakthrough therapies are...
Recent Comments